Obstetrics & Gynecology · Petaluma, CA
NPI
1942475710
Since 2008
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3900 Lakeville Hwy
Petaluma, CA, 94954
Phone (707) 765-3900
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$102K
1,075 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Elmira Manoucheri prescribed most often to Medicare patients was Estradiol, with 251 prescriptions and refills. In total Elmira Manoucheri wrote 1,075 Medicare prescriptions that cost $102K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 251 | 864 | 157 | $10K |
| Progesterone Progesterone, Micronized | 89 | 237 | 46 | $3,777 |
| Estring Estradiol | 87 | 254 | 34 | $53K |
| Yuvafem Estradiol | 78 | 199 | 40 | $8,699 |
| Climara Estradiol | 74 | 199 | 28 | $9,998 |
| Acyclovir Generic | 52 | 107 | 28 | $1,102 |
| Clobetasol Propionate Generic | 48 | 49 | 37 | $732 |
| Fluconazole Generic | 47 | 47 | 23 | $305 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 40 | 40 | 27 | $1,504 |
| Trospium Chloride Generic | 23 | 72 | Under 11 | $878 |
| Nystatin Generic | 17 | 17 | 11 | $384 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 17 | 16 | $101 |
| Cefadroxil Generic | 16 | 16 | 14 | $194 |
| Betamethasone Valerate Generic | 16 | 16 | Under 11 | $504 |
| Lidocaine Generic | 15 | 15 | 11 | $201 |
Brand drugs: 185 claims; generic drugs: 890 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Elmira Manoucheri were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.